Highlights
TSX: GEN       Genenews Limited
Last Price Today's Change   Day's Range   Trading Volume
0.15   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):0
52 Weeks Range:0.03 - 0.04
52 Weeks Price Volatility (%):
375.00%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

GeneNews Ltd is a Canada-based company focused on developing and commercializing proprietary molecular diagnostic tests for early detection of cancer. It has developed Sentinel Principle platform technology, which determines biomarkers from whole blood. In additional, the Company offers ColonSentry product, it is a blood test to determine an individual's current risk for having colorectal cancer. The Company operates within the biotechnology, molecular diagnostic and genomic biomarker industry. GeneNews has subsidiaries in Canada and the United states. The Company's partners include JTS Health Partners and NueHealth, which are located in the United States.

  Be the first to like this.
 


 

721  922  1225  1685 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ACB 3.00-0.59 
 ECA 5.50-0.26 
 APHA 5.03-0.62 
 PXI 0.065+0.005 
 TGOD 0.65-0.05 
 OGC 2.66+0.06 
 WEED 18.78-1.51 
 CPG 5.21-0.08 
 BTO 4.77+0.14 
 PEY 2.86-0.18 
Partners & Brokers